|
2019 CONFERENCE SPEAKERS
|
|
|---|---|
 |
Ron Mazumder, PhD, VP, Global Head of Oncology Biomarker. Keynote: Biomakers and Translational Research in Cancer Therapy |
 |
Jason Liu, PhD, MBA, CEO, WuXi Diagnostics. New Diagnostics Ecosystem to Accelerate Drug Discovery and Medical Innovation |
 |
John V. Oyler, Founder, CEO and Chairman CABS 2019 K. Fong Awardee Speech. The Future of the Biopharma Industry: Innovation Beyond Science |
 |
Romas Geleziunas, PhD, Executive Director, Biology Designing Therapies to Cure HIV |
 |
Joseph Benkert, Senior Advisor, National Security Group. Key Developments: CFIUS, Export Control Reform, and Recent Decisions Affectiong Life Sciences Investment and Licensing |
 |
Zachary Sweeney, PhD, Head of Therapeutic Discovery. New Approaches To Neurodegenerative Disease Drug Discovery and Development |
 |
Shivaani Kummar, MD, Professor of Medicine. Applying Precision Medicine One Patient at a Time |
 |
Leonard Post, PhD, CSO. Talazoparib: From Virtual Drug Discovery to FDA Approval |
| and more | |
2019 speakersYash Paul2021-09-10T09:05:45+00:00